Kidney function study aims to understand drug breakdown
NCT ID NCT07165015
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 25 times
Summary
This study looked at how the drug LY3537031 enters the blood and leaves the body in people with different levels of kidney function. 31 adults, some with kidney impairment and some healthy, took a single dose. The goal was to gather safety and processing data, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Indiana University School of Medicine
Indianapolis, Indiana, 46202-5188, United States
-
New Zealand Clinical Research Christchurch
Christchurch, New Zealand
-
Omega Research Orlando LLC
Orlando, Florida, 32808, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
Conditions
Explore the condition pages connected to this study.